Last update 01 Nov 2024
Apsen Farmaceutica S/A

Apsen Farmaceutica S/A

Private Company|
1969|
Brazil
|
500-1,000
|
www.apsen.com.br

Overview

Tags

Nervous System Diseases
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Chemical drugs1

Related

3
Drugs associated with Apsen Farmaceutica S/A
Ibuprofen
Target
COX
Mechanism
COX inhibitors
Active Org.
Overseas Pharmaceuticals Ltd.Overseas Pharmaceuticals Ltd. [+21]
Originator Org.
Johnson & JohnsonJohnson & Johnson
Active Indication
Ductus Arteriosus, Patent [+29]
Inactive Indication
Acute Pain [+17]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 1966
APSCTC
Target-
Mechanism-
Active Org.
Apsen Farmaceutica S/AApsen Farmaceutica S/A
Originator Org.
Apsen Farmaceutica S/AApsen Farmaceutica S/A
Active Indication
Pain, Postoperative
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
APSLXR
Target-
Mechanism-
Active Org.-
Originator Org.
Apsen Farmaceutica S/AApsen Farmaceutica S/A
Active Indication-
Inactive Indication
Meniere Disease [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
14
Clinical Trials associated with Apsen Farmaceutica S/A
NCT04647435 / RecruitingPhase 3
National, Multicentre, Randomized, Double-blind, Triple-dummy Active-Controled Phase III Clinical Trial to Evaluate the Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction.
NCT04674735 / WithdrawnPhase 1
Multicentre, Open Label, Phase I Clinical Trial to Evaluate the Safety of APSLXR for the Treatment of Vertigo of Vestibular Origin or Meniere's Disease
NCT04637529 / CompletedPhase 2
National, Multicentre, Randomized, Double-blind, Double-dummy Phase II Clinical Trial to Evaluate the Efficacy and Safety of S (+) - Ibuprofen for Pain Control in Individuals With Osteoarthritis
100 Clinical Results associated with Apsen Farmaceutica S/A
Login to view more data
0 Patents (Medical) associated with Apsen Farmaceutica S/A
Login to view more data
100 Deals associated with Apsen Farmaceutica S/A
Login to view more data
100 Translational Medicine associated with Apsen Farmaceutica S/A
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
APSCTC
Pain, Postoperative
More
Phase 3
APSLXR
Vestibular dysfunction - vertigo
More
Discontinued
Ibuprofen
 ( COX )		Low Back Pain
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free